Ghulam Rahim Awab

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

Paul N. Newton, Katherine C. Bond, Moji Christianah Adeyeye et al. · The Lancet Global Health · 2020 · 167 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +10

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial

Ghulam Rahim Awab, Sasithon Pukrittayakamee, Mallika Imwong et al. · Malaria Journal · 2010 · 61 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Global access to quality-assured medical products: the Oxford Statement and call to action

Paul N. Newton, Katherine C. Bond, Paul N. Newton et al. · The Lancet Global Health · 2019 · 56 citations · Full text

Pharmacy, Pharmaceutical Policy, Global Health +15

Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in The Guianas: a descriptive epidemiological study

Célia Florimond, Franck de Laval, Angela M. Early et al. · The Lancet Infectious Diseases · 2023 · 36 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Rolling out the radical cure for vivax malaria in Asia: a qualitative study among policy makers and stakeholders

Bipin Adhikari, Ghulam Rahim Awab, Lorenz von Seidlein · Malaria Journal · 2021 · 28 citations · Full text

Public Affairs, Health Policy, Infectious Disease Control +16